{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8e35c29e-7193-4b25-841f-047cffa3b619",
   "metadata": {},
   "source": [
    "# 1. Handle single step queries e.g. \n",
    "- [x] \"What are the targets of vorinostat?\"\n",
    "- [x] \"Find drugs that are used for treating ulcerative colitis.\" etc.\n",
    "# 2. Handle 2-step queries e.g. \n",
    "- [x] \"Which diseases are associated with the genes targetted by fasudil?\"\n",
    "- [ ] \"Show all the diseases that have at least 5 pathways associated with Alzheimer\"\n",
    "  - NOTE: I do not think graphql supports carrying this out in a single operation given the open targets schema does not provide any resolvers or function/field to enable us to link pathways back to targets or to count entities based on this association from disease->gene->pathway and use that aggregation as part of a filter. This could be carried out as a multi-query by the client, but that seems to be beyond the intended scope of this exercise. Implementing that with natural human language interpretation by GPT would likely also require us to ask gpt to help us write code to interpret the results of a possibly infinite number of asks that cannot be fulfilled by the current open targets schema in a single query, and somehow ensuring that executing that functionality in the current python session would work correctly. Implementing something like that would take a bit longer than I think this task was intended to take, so I am going to leave this particular feature unimplemented, and make sure the script has the capacity to report when the constructed queries cause an error (as this one does)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "d4884138-c8be-4738-8f78-6da2a76b12f0",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import sys\n",
    "import re\n",
    "import json\n",
    "import requests\n",
    "import openai\n",
    "from datetime import datetime\n",
    "from utils import extract_values\n",
    "from urlpath import URL"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "f248a95c-4d2a-4920-8eef-814baca2a1d5",
   "metadata": {},
   "outputs": [],
   "source": [
    "opentargets_base_url = \"https://api.platform.opentargets.org/api/v4/graphql\"\n",
    "open_targets_base = URL(opentargets_base_url)\n",
    "open_targets_schema_url = open_targets_base / \"schema\"\n",
    "schema_response = open_targets_schema_url.get()\n",
    "open_targets_schema = schema_response.content.decode()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "c30c1fad-967d-4682-85d7-e6c7e98fa70b",
   "metadata": {},
   "outputs": [],
   "source": [
    "openai.api_key = os.environ.get(\"OPENAI_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "07eb7364-a319-4edf-bdbc-735786a571cb",
   "metadata": {},
   "outputs": [],
   "source": [
    "models = openai.Model.list()\n",
    "model_ids = []\n",
    "for item in models['data']:\n",
    "    model_ids.append(item['id'])\n",
    "sorted(model_ids)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "46b392d2-932c-4823-9c53-0d47384b8807",
   "metadata": {},
   "outputs": [],
   "source": [
    "# gpt_model = 'gpt-3.5-turbo-16k'\n",
    "gpt_model = 'gpt-4'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "62b559e9-74f4-4675-8c49-250cb8621131",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Open Targets graphQL schema example\n",
    "# read from file\n",
    "with open(\"graphql_schema.txt\", \"r\") as f:\n",
    "    prompt_templates = f.read()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "5d5dc9f9-353f-4628-8afa-0c1f7cb0640d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_query_for_opentargets_using_human_language(user_input):\n",
    "    completion_prompt = \"\\nGiven this schema, what resources would be required to retrieve the results of this query: \"\n",
    "    resource_messages = [{'role':'user', 'content': \"The following is the schema provided by Open Targets for their graphQL API:\\n\" + open_targets_schema + \"\\n\\n\" + completion_prompt + user_input}]\n",
    "    resource_response = openai.ChatCompletion.create(\n",
    "        model=gpt_model,\n",
    "        messages=resource_messages,\n",
    "        temperature=0,\n",
    "        max_tokens=250,\n",
    "        top_p=1,\n",
    "        frequency_penalty=0,\n",
    "        presence_penalty=0,\n",
    "        stop=[\"###\"],\n",
    "    )\n",
    "    resource_response_message = resource_response['choices'][0]['message']\n",
    "    graphql_messages = [\n",
    "        {\n",
    "            'role':'user',\n",
    "            'content': resource_response_message['content']\n",
    "        },\n",
    "        {\n",
    "            'role':'user',\n",
    "            'content': 'Here are some example queries: \\n' + prompt_templates\n",
    "        },\n",
    "        {\n",
    "        'role':'user',\n",
    "        'content': 'Please do not include extra variables not in the examples. Do not tranform or translate any drug, disease or gene names into chemblId, EFO ID, or ENSEMBL ID. Follow the examples strictly. Do not include extra variables in the query. Please use the resources listed and the example queries to generate a graphQL expression that fetches all the required data to complete the query: \"' + user_input + \"; query generated_query {\\n  search(\"\n",
    "        }\n",
    "    ]\n",
    "    graphql_response = openai.ChatCompletion.create(\n",
    "        model=gpt_model,\n",
    "        messages=graphql_messages,\n",
    "        temperature=0,\n",
    "        max_tokens=500,\n",
    "        top_p=1,\n",
    "        frequency_penalty=0,\n",
    "        presence_penalty=0,\n",
    "        stop=[\"###\"],\n",
    "    )\n",
    "    return \"query generated_query {\\n  search(\" + graphql_response['choices'][0]['message']['content']\n",
    "def store_custom_query(user_input, query_string):\n",
    "    query_file = \"query_\" + datetime.now().strftime(\"%Y_%m_%d-%I_%M_%S_%p\") + \".txt\"\n",
    "    with open(query_file, \"w\") as f:\n",
    "        f.write(f\"# User input: {user_input}\\n\")\n",
    "        f.write(query_string)\n",
    "        #print(f\"\\nCustom graphQL query was written to file: {query_file}\")\n",
    "        \n",
    "def perform_opentargets_query(query):\n",
    "    # Perform POST request and check status code of response\n",
    "    # This handles the cases where the Open Targets API is down or our query is invalid\n",
    "    try:\n",
    "        response = open_targets_base.post(json={\"query\": query})\n",
    "        response.raise_for_status()\n",
    "    except requests.exceptions.HTTPError as err:\n",
    "        print(err, file=sys.stderr)\n",
    "        print(response.content.decode(), file=sys.stderr)\n",
    "        return None\n",
    "    except:\n",
    "        the_type, the_value, the_traceback = sys.exc_info()\n",
    "        print(\"exception occurred: %s -> %s\" % (str(the_type), str(the_value)), file=sys.stderr)\n",
    "        return None\n",
    "    \n",
    "    return response.content.decode()\n",
    "\n",
    "def test_input(user_input):\n",
    "    test_result = generate_query_for_opentargets_using_human_language(user_input)\n",
    "    store_custom_query(user_input, test_result)\n",
    "    test_query_result = perform_opentargets_query(test_result)\n",
    "    return test_result, test_query_result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "bbf7a4a9-9725-4f50-a7a5-9ead511e31ab",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "query generated_query {\n",
      "  search(queryString: \"vorinostat\", entityNames: \"drug\", page: {index: 0, size: 1}) {\n",
      "    hits {\n",
      "      id\n",
      "      name\n",
      "      entity\n",
      "      object {\n",
      "        ... on Drug {\n",
      "          mechanismsOfAction {\n",
      "            rows {\n",
      "              targets {\n",
      "                id\n",
      "                approvedSymbol\n",
      "              }\n",
      "            }\n",
      "          }\n",
      "        }\n",
      "      }\n",
      "    }\n",
      "  }\n",
      "}\n",
      "{\"data\":{\"search\":{\"hits\":[{\"id\":\"CHEMBL98\",\"name\":\"VORINOSTAT\",\"entity\":\"drug\",\"object\":{\"mechanismsOfAction\":{\"rows\":[{\"targets\":[{\"id\":\"ENSG00000171720\",\"approvedSymbol\":\"HDAC3\"}]},{\"targets\":[{\"id\":\"ENSG00000094631\",\"approvedSymbol\":\"HDAC6\"}]},{\"targets\":[{\"id\":\"ENSG00000116478\",\"approvedSymbol\":\"HDAC1\"}]},{\"targets\":[{\"id\":\"ENSG00000196591\",\"approvedSymbol\":\"HDAC2\"}]}]}}}]}}}\n",
      "query generated_query {\n",
      "  search(queryString: \"ulcerative colitis\", entityNames: \"disease\", page: {index: 0, size: 1}) {\n",
      "    hits {\n",
      "      id\n",
      "      name\n",
      "      entity\n",
      "      object {\n",
      "        ... on Disease {\n",
      "          knownDrugs {\n",
      "            rows {\n",
      "              drugId\n",
      "              prefName\n",
      "            }\n",
      "          }\n",
      "        }\n",
      "      }\n",
      "    }\n",
      "  }\n",
      "}\n",
      "{\"data\":{\"search\":{\"hits\":[{\"id\":\"EFO_0000729\",\"name\":\"ulcerative colitis\",\"entity\":\"disease\",\"object\":{\"knownDrugs\":{\"rows\":[{\"drugId\":\"CHEMBL421\",\"prefName\":\"SULFASALAZINE\"},{\"drugId\":\"CHEMBL1370\",\"prefName\":\"BUDESONIDE\"},{\"drugId\":\"CHEMBL1433\",\"prefName\":\"DOXYCYCLINE ANHYDROUS\"},{\"drugId\":\"CHEMBL1201580\",\"prefName\":\"ADALIMUMAB\"},{\"drugId\":\"CHEMBL1433\",\"prefName\":\"DOXYCYCLINE ANHYDROUS\"},{\"drugId\":\"CHEMBL1201833\",\"prefName\":\"GOLIMUMAB\"},{\"drugId\":\"CHEMBL635\",\"prefName\":\"PREDNISONE\"},{\"drugId\":\"CHEMBL1200699\",\"prefName\":\"DOXYCYCLINE\"},{\"drugId\":\"CHEMBL1743087\",\"prefName\":\"VEDOLIZUMAB\"},{\"drugId\":\"CHEMBL1201580\",\"prefName\":\"ADALIMUMAB\"},{\"drugId\":\"CHEMBL650\",\"prefName\":\"METHYLPREDNISOLONE\"},{\"drugId\":\"CHEMBL704\",\"prefName\":\"MESALAMINE\"},{\"drugId\":\"CHEMBL1200762\",\"prefName\":\"BETAMETHASONE SODIUM PHOSPHATE\"},{\"drugId\":\"CHEMBL704\",\"prefName\":\"MESALAMINE\"},{\"drugId\":\"CHEMBL1201581\",\"prefName\":\"INFLIXIMAB\"},{\"drugId\":\"CHEMBL421\",\"prefName\":\"SULFASALAZINE\"},{\"drugId\":\"CHEMBL635\",\"prefName\":\"PREDNISONE\"},{\"drugId\":\"CHEMBL704\",\"prefName\":\"MESALAMINE\"},{\"drugId\":\"CHEMBL655\",\"prefName\":\"MIDAZOLAM\"},{\"drugId\":\"CHEMBL704\",\"prefName\":\"MESALAMINE\"},{\"drugId\":\"CHEMBL635\",\"prefName\":\"PREDNISONE\"},{\"drugId\":\"CHEMBL1200699\",\"prefName\":\"DOXYCYCLINE\"},{\"drugId\":\"CHEMBL1201346\",\"prefName\":\"BALSALAZIDE\"},{\"drugId\":\"CHEMBL221959\",\"prefName\":\"TOFACITINIB\"},{\"drugId\":\"CHEMBL425\",\"prefName\":\"OLSALAZINE\"}]}}}]}}}\n",
      "query generated_query {\n",
      "  search(queryString: \"fasudil\", entityNames: \"drug\", page: {index: 0, size: 1}) {\n",
      "    hits {\n",
      "      id\n",
      "      name\n",
      "      entity\n",
      "      object {\n",
      "        ... on Drug {\n",
      "          linkedTargets {\n",
      "            rows {\n",
      "              approvedSymbol\n",
      "              ... on Target {\n",
      "                associatedDiseases {\n",
      "                  rows {\n",
      "                    score\n",
      "                    disease {\n",
      "                      id\n",
      "                      name\n",
      "                    }\n",
      "                  }\n",
      "                }\n",
      "              }\n",
      "            }\n",
      "          }\n",
      "        }\n",
      "      }\n",
      "    }\n",
      "  }\n",
      "}\n",
      "{\"data\":{\"search\":{\"hits\":[{\"id\":\"CHEMBL38380\",\"name\":\"FASUDIL\",\"entity\":\"drug\",\"object\":{\"linkedTargets\":{\"rows\":[{\"approvedSymbol\":\"ROCK2\",\"associatedDiseases\":{\"rows\":[{\"score\":0.5580112081648932,\"disease\":{\"id\":\"EFO_0004190\",\"name\":\"open-angle glaucoma\"}},{\"score\":0.5570338462445541,\"disease\":{\"id\":\"EFO_1001069\",\"name\":\"ocular hypertension\"}},{\"score\":0.5478429832481734,\"disease\":{\"id\":\"EFO_0005772\",\"name\":\"neurodegenerative disease\"}},{\"score\":0.5052279849309224,\"disease\":{\"id\":\"MONDO_0005041\",\"name\":\"glaucoma\"}},{\"score\":0.4715736284706049,\"disease\":{\"id\":\"MONDO_0013730\",\"name\":\"graft versus host disease\"}},{\"score\":0.46605046286448354,\"disease\":{\"id\":\"Orphanet_98974\",\"name\":\"Fuchs endothelial corneal dystrophy\"}},{\"score\":0.40047013678235266,\"disease\":{\"id\":\"EFO_0004526\",\"name\":\"mean corpuscular volume\"}},{\"score\":0.3761867338373383,\"disease\":{\"id\":\"EFO_0004587\",\"name\":\"lymphocyte count\"}},{\"score\":0.37367454435923936,\"disease\":{\"id\":\"EFO_0004339\",\"name\":\"body height\"}},{\"score\":0.3720764692641677,\"disease\":{\"id\":\"EFO_0000612\",\"name\":\"myocardial infarction\"}},{\"score\":0.3695798546847018,\"disease\":{\"id\":\"EFO_1001022\",\"name\":\"low tension glaucoma\"}},{\"score\":0.3695798546847018,\"disease\":{\"id\":\"EFO_0000540\",\"name\":\"immune system disease\"}},{\"score\":0.34449779007508613,\"disease\":{\"id\":\"EFO_0007788\",\"name\":\"BMI-adjusted waist-hip ratio\"}},{\"score\":0.32747009105961955,\"disease\":{\"id\":\"EFO_0007800\",\"name\":\"body fat percentage\"}},{\"score\":0.32464439018738533,\"disease\":{\"id\":\"EFO_0007984\",\"name\":\"platelet component distribution width\"}},{\"score\":0.3201710930473081,\"disease\":{\"id\":\"EFO_0010701\",\"name\":\"mean reticulocyte volume\"}},{\"score\":0.31328473619297864,\"disease\":{\"id\":\"EFO_0004464\",\"name\":\"brain measurement\"}},{\"score\":0.31282878665806985,\"disease\":{\"id\":\"EFO_0004840\",\"name\":\"cortical thickness\"}},{\"score\":0.29525093859405127,\"disease\":{\"id\":\"EFO_0004532\",\"name\":\"serum gamma-glutamyl transferase measurement\"}},{\"score\":0.27755447086821106,\"disease\":{\"id\":\"EFO_0000319\",\"name\":\"cardiovascular disease\"}},{\"score\":0.27718489101352634,\"disease\":{\"id\":\"EFO_1000879\",\"name\":\"corneal edema\"}},{\"score\":0.26644582337094425,\"disease\":{\"id\":\"EFO_0004980\",\"name\":\"appendicular lean mass\"}},{\"score\":0.2660512016698931,\"disease\":{\"id\":\"EFO_0004611\",\"name\":\"low density lipoprotein cholesterol measurement\"}},{\"score\":0.2658871320913831,\"disease\":{\"id\":\"EFO_0004193\",\"name\":\"basal cell carcinoma\"}},{\"score\":0.262697269669774,\"disease\":{\"id\":\"EFO_0004518\",\"name\":\"creatinine measurement\"}}]}},{\"approvedSymbol\":\"ROCK1\",\"associatedDiseases\":{\"rows\":[{\"score\":0.5589710891763661,\"disease\":{\"id\":\"EFO_0004190\",\"name\":\"open-angle glaucoma\"}},{\"score\":0.5577730059539234,\"disease\":{\"id\":\"EFO_1001069\",\"name\":\"ocular hypertension\"}},{\"score\":0.5541525010625129,\"disease\":{\"id\":\"EFO_0005772\",\"name\":\"neurodegenerative disease\"}},{\"score\":0.5042300153029697,\"disease\":{\"id\":\"MONDO_0005041\",\"name\":\"glaucoma\"}},{\"score\":0.4701877040155372,\"disease\":{\"id\":\"MONDO_0013730\",\"name\":\"graft versus host disease\"}},{\"score\":0.46605046286448354,\"disease\":{\"id\":\"Orphanet_98974\",\"name\":\"Fuchs endothelial corneal dystrophy\"}},{\"score\":0.37207215435651053,\"disease\":{\"id\":\"EFO_0000612\",\"name\":\"myocardial infarction\"}},{\"score\":0.3695798546847018,\"disease\":{\"id\":\"EFO_0000540\",\"name\":\"immune system disease\"}},{\"score\":0.3695798546847018,\"disease\":{\"id\":\"EFO_1001022\",\"name\":\"low tension glaucoma\"}},{\"score\":0.27907385471524815,\"disease\":{\"id\":\"EFO_0000319\",\"name\":\"cardiovascular disease\"}},{\"score\":0.27718489101352634,\"disease\":{\"id\":\"EFO_1000879\",\"name\":\"corneal edema\"}},{\"score\":0.2732051836250793,\"disease\":{\"id\":\"EFO_0000304\",\"name\":\"breast adenocarcinoma\"}},{\"score\":0.26045228777127727,\"disease\":{\"id\":\"EFO_0000519\",\"name\":\"glioblastoma multiforme\"}},{\"score\":0.25870589827929125,\"disease\":{\"id\":\"EFO_0001071\",\"name\":\"lung carcinoma\"}},{\"score\":0.25870589827929125,\"disease\":{\"id\":\"EFO_0003869\",\"name\":\"breast neoplasm\"}},{\"score\":0.2414183098078613,\"disease\":{\"id\":\"MONDO_0011962\",\"name\":\"endometrial cancer\"}},{\"score\":0.23666759138754176,\"disease\":{\"id\":\"EFO_0004536\",\"name\":\"total blood protein measurement\"}},{\"score\":0.23666759138754176,\"disease\":{\"id\":\"EFO_0007937\",\"name\":\"blood protein measurement\"}},{\"score\":0.23562508429798926,\"disease\":{\"id\":\"EFO_0004526\",\"name\":\"mean corpuscular volume\"}},{\"score\":0.21018095064723594,\"disease\":{\"id\":\"EFO_0000181\",\"name\":\"head and neck squamous cell carcinoma\"}},{\"score\":0.1893910938721047,\"disease\":{\"id\":\"EFO_0000571\",\"name\":\"lung adenocarcinoma\"}},{\"score\":0.1797174647880423,\"disease\":{\"id\":\"EFO_0000508\",\"name\":\"genetic disorder\"}},{\"score\":0.15834298188018614,\"disease\":{\"id\":\"EFO_0011011\",\"name\":\"sitting height measurement\"}},{\"score\":0.1558526070205022,\"disease\":{\"id\":\"EFO_0004518\",\"name\":\"creatinine measurement\"}},{\"score\":0.14676786678639553,\"disease\":{\"id\":\"EFO_0000503\",\"name\":\"gastric adenocarcinoma\"}}]}}]}}}]}}}\n",
      "query generated_query {\n",
      "  search(queryString: \"breast cancer\", entityNames: \"disease\", page: {index: 0, size: 1}) {\n",
      "    hits {\n",
      "      id\n",
      "      name\n",
      "      object {\n",
      "        ... on Disease {\n",
      "          associatedTargets {\n",
      "            rows {\n",
      "              target {\n",
      "                id\n",
      "                approvedSymbol\n",
      "                pathways {\n",
      "                  pathwayId\n",
      "                  pathway\n",
      "                }\n",
      "              }\n",
      "            }\n",
      "          }\n",
      "        }\n",
      "      }\n",
      "    }\n",
      "  }\n",
      "}\n",
      "{\"data\":{\"search\":{\"hits\":[{\"id\":\"MONDO_0007254\",\"name\":\"breast cancer\",\"object\":{\"associatedTargets\":{\"rows\":[{\"target\":{\"id\":\"ENSG00000139618\",\"approvedSymbol\":\"BRCA2\",\"pathways\":[{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-5693616\",\"pathway\":\"Presynaptic phase of homologous DNA pairing and strand exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-9709570\",\"pathway\":\"Impaired BRCA2 binding to RAD51\"},{\"pathwayId\":\"R-HSA-9763198\",\"pathway\":\"Impaired BRCA2 binding to SEM1 (DSS1)\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-912446\",\"pathway\":\"Meiotic recombination\"},{\"pathwayId\":\"R-HSA-5685939\",\"pathway\":\"HDR through MMEJ (alt-NHEJ)\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9709275\",\"pathway\":\"Impaired BRCA2 translocation to the nucleus\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"}]}},{\"target\":{\"id\":\"ENSG00000012048\",\"approvedSymbol\":\"BRCA1\",\"pathways\":[{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-5693616\",\"pathway\":\"Presynaptic phase of homologous DNA pairing and strand exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-6804756\",\"pathway\":\"Regulation of TP53 Activity through Phosphorylation\"},{\"pathwayId\":\"R-HSA-9663199\",\"pathway\":\"Defective DNA double strand break response due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-6796648\",\"pathway\":\"TP53 Regulates Transcription of DNA Repair Genes\"},{\"pathwayId\":\"R-HSA-9709570\",\"pathway\":\"Impaired BRCA2 binding to RAD51\"},{\"pathwayId\":\"R-HSA-5693607\",\"pathway\":\"Processing of DNA double-strand break ends\"},{\"pathwayId\":\"R-HSA-5689901\",\"pathway\":\"Metalloprotease DUBs\"},{\"pathwayId\":\"R-HSA-9755511\",\"pathway\":\"KEAP1-NFE2L2 pathway\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-8953750\",\"pathway\":\"Transcriptional Regulation by E2F6\"},{\"pathwayId\":\"R-HSA-69473\",\"pathway\":\"G2/M DNA damage checkpoint\"},{\"pathwayId\":\"R-HSA-5693571\",\"pathway\":\"Nonhomologous End-Joining (NHEJ)\"},{\"pathwayId\":\"R-HSA-1221632\",\"pathway\":\"Meiotic synapsis\"},{\"pathwayId\":\"R-HSA-912446\",\"pathway\":\"Meiotic recombination\"},{\"pathwayId\":\"R-HSA-3108214\",\"pathway\":\"SUMOylation of DNA damage response and repair proteins\"},{\"pathwayId\":\"R-HSA-9699150\",\"pathway\":\"Defective DNA double strand break response due to BARD1 loss of function\"},{\"pathwayId\":\"R-HSA-8951664\",\"pathway\":\"Neddylation\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-5693565\",\"pathway\":\"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5685938\",\"pathway\":\"HDR through Single Strand Annealing (SSA)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"}]}},{\"target\":{\"id\":\"ENSG00000121879\",\"approvedSymbol\":\"PIK3CA\",\"pathways\":[{\"pathwayId\":\"R-HSA-6811558\",\"pathway\":\"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling\"},{\"pathwayId\":\"R-HSA-114604\",\"pathway\":\"GPVI-mediated activation cascade\"},{\"pathwayId\":\"R-HSA-4420097\",\"pathway\":\"VEGFA-VEGFR2 Pathway\"},{\"pathwayId\":\"R-HSA-8851907\",\"pathway\":\"MET activates PI3K/AKT signaling\"},{\"pathwayId\":\"R-HSA-9725370\",\"pathway\":\"Signaling by ALK fusions and activated point mutants\"},{\"pathwayId\":\"R-HSA-9670439\",\"pathway\":\"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants\"},{\"pathwayId\":\"R-HSA-5673001\",\"pathway\":\"RAF/MAP kinase cascade\"},{\"pathwayId\":\"R-HSA-5655291\",\"pathway\":\"Signaling by FGFR4 in disease\"},{\"pathwayId\":\"R-HSA-5655253\",\"pathway\":\"Signaling by FGFR2 in disease\"},{\"pathwayId\":\"R-HSA-201556\",\"pathway\":\"Signaling by ALK\"},{\"pathwayId\":\"R-HSA-180292\",\"pathway\":\"GAB1 signalosome\"},{\"pathwayId\":\"R-HSA-5655332\",\"pathway\":\"Signaling by FGFR3 in disease\"},{\"pathwayId\":\"R-HSA-9664565\",\"pathway\":\"Signaling by ERBB2 KD Mutants\"},{\"pathwayId\":\"R-HSA-1250342\",\"pathway\":\"PI3K events in ERBB4 signaling\"},{\"pathwayId\":\"R-HSA-416476\",\"pathway\":\"G alpha (q) signalling events\"},{\"pathwayId\":\"R-HSA-2424491\",\"pathway\":\"DAP12 signaling\"},{\"pathwayId\":\"R-HSA-1257604\",\"pathway\":\"PIP3 activates AKT signaling\"},{\"pathwayId\":\"R-HSA-2730905\",\"pathway\":\"Role of LAT2/NTAL/LAB on calcium mobilization\"},{\"pathwayId\":\"R-HSA-9673767\",\"pathway\":\"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants\"},{\"pathwayId\":\"R-HSA-8853659\",\"pathway\":\"RET signaling\"},{\"pathwayId\":\"R-HSA-1963642\",\"pathway\":\"PI3K events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-2029485\",\"pathway\":\"Role of phospholipids in phagocytosis\"},{\"pathwayId\":\"R-HSA-5654695\",\"pathway\":\"PI-3K cascade:FGFR2\"},{\"pathwayId\":\"R-HSA-1660499\",\"pathway\":\"Synthesis of PIPs at the plasma membrane\"},{\"pathwayId\":\"R-HSA-112399\",\"pathway\":\"IRS-mediated signalling\"},{\"pathwayId\":\"R-HSA-9703465\",\"pathway\":\"Signaling by FLT3 fusion proteins\"},{\"pathwayId\":\"R-HSA-912631\",\"pathway\":\"Regulation of signaling by CBL\"},{\"pathwayId\":\"R-HSA-9673770\",\"pathway\":\"Signaling by PDGFRA extracellular domain mutants\"},{\"pathwayId\":\"R-HSA-202424\",\"pathway\":\"Downstream TCR signaling\"},{\"pathwayId\":\"R-HSA-1433557\",\"pathway\":\"Signaling by SCF-KIT\"},{\"pathwayId\":\"R-HSA-9009391\",\"pathway\":\"Extra-nuclear estrogen signaling\"},{\"pathwayId\":\"R-HSA-9607240\",\"pathway\":\"FLT3 Signaling\"},{\"pathwayId\":\"R-HSA-5637810\",\"pathway\":\"Constitutive Signaling by EGFRvIII\"},{\"pathwayId\":\"R-HSA-9028335\",\"pathway\":\"Activated NTRK2 signals through PI3K\"},{\"pathwayId\":\"R-HSA-109704\",\"pathway\":\"PI3K Cascade\"},{\"pathwayId\":\"R-HSA-210993\",\"pathway\":\"Tie2 Signaling\"},{\"pathwayId\":\"R-HSA-186763\",\"pathway\":\"Downstream signal transduction\"},{\"pathwayId\":\"R-HSA-198203\",\"pathway\":\"PI3K/AKT activation\"},{\"pathwayId\":\"R-HSA-9603381\",\"pathway\":\"Activated NTRK3 signals through PI3K\"},{\"pathwayId\":\"R-HSA-9013404\",\"pathway\":\"RAC2 GTPase cycle\"},{\"pathwayId\":\"R-HSA-5654720\",\"pathway\":\"PI-3K cascade:FGFR4\"},{\"pathwayId\":\"R-HSA-373753\",\"pathway\":\"Nephrin family interactions\"},{\"pathwayId\":\"R-HSA-9703648\",\"pathway\":\"Signaling by FLT3 ITD and TKD mutants\"},{\"pathwayId\":\"R-HSA-1236382\",\"pathway\":\"Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants\"},{\"pathwayId\":\"R-HSA-5655302\",\"pathway\":\"Signaling by FGFR1 in disease\"},{\"pathwayId\":\"R-HSA-1839117\",\"pathway\":\"Signaling by cytosolic FGFR1 fusion mutants\"},{\"pathwayId\":\"R-HSA-9680350\",\"pathway\":\"Signaling by CSF1 (M-CSF) in myeloid cells\"},{\"pathwayId\":\"R-HSA-2219530\",\"pathway\":\"Constitutive Signaling by Aberrant PI3K in Cancer\"},{\"pathwayId\":\"R-HSA-389357\",\"pathway\":\"CD28 dependent PI3K/Akt signaling\"},{\"pathwayId\":\"R-HSA-5654689\",\"pathway\":\"PI-3K cascade:FGFR1\"},{\"pathwayId\":\"R-HSA-388841\",\"pathway\":\"Costimulation by the CD28 family\"},{\"pathwayId\":\"R-HSA-9027276\",\"pathway\":\"Erythropoietin activates Phosphoinositide-3-kinase (PI3K)\"},{\"pathwayId\":\"R-HSA-9665348\",\"pathway\":\"Signaling by ERBB2 ECD mutants\"},{\"pathwayId\":\"R-HSA-512988\",\"pathway\":\"Interleukin-3, Interleukin-5 and GM-CSF signaling\"},{\"pathwayId\":\"R-HSA-9013149\",\"pathway\":\"RAC1 GTPase cycle\"},{\"pathwayId\":\"R-HSA-5654710\",\"pathway\":\"PI-3K cascade:FGFR3\"},{\"pathwayId\":\"R-HSA-912526\",\"pathway\":\"Interleukin receptor SHC signaling\"}]}},{\"target\":{\"id\":\"ENSG00000183765\",\"approvedSymbol\":\"CHEK2\",\"pathways\":[{\"pathwayId\":\"R-HSA-6804756\",\"pathway\":\"Regulation of TP53 Activity through Phosphorylation\"},{\"pathwayId\":\"R-HSA-6804760\",\"pathway\":\"Regulation of TP53 Activity through Methylation\"},{\"pathwayId\":\"R-HSA-5693565\",\"pathway\":\"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks\"},{\"pathwayId\":\"R-HSA-75035\",\"pathway\":\"Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex\"},{\"pathwayId\":\"R-HSA-69473\",\"pathway\":\"G2/M DNA damage checkpoint\"},{\"pathwayId\":\"R-HSA-69601\",\"pathway\":\"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A\"},{\"pathwayId\":\"R-HSA-69541\",\"pathway\":\"Stabilization of p53\"},{\"pathwayId\":\"R-HSA-6804757\",\"pathway\":\"Regulation of TP53 Degradation\"}]}},{\"target\":{\"id\":\"ENSG00000141510\",\"approvedSymbol\":\"TP53\",\"pathways\":[{\"pathwayId\":\"R-HSA-3232118\",\"pathway\":\"SUMOylation of transcription factors\"},{\"pathwayId\":\"R-HSA-2559586\",\"pathway\":\"DNA Damage/Telomere Stress Induced Senescence\"},{\"pathwayId\":\"R-HSA-6804756\",\"pathway\":\"Regulation of TP53 Activity through Phosphorylation\"},{\"pathwayId\":\"R-HSA-349425\",\"pathway\":\"Autodegradation of the E3 ubiquitin ligase COP1\"},{\"pathwayId\":\"R-HSA-2559580\",\"pathway\":\"Oxidative Stress Induced Senescence\"},{\"pathwayId\":\"R-HSA-9758274\",\"pathway\":\"Regulation of NF-kappa B signaling\"},{\"pathwayId\":\"R-HSA-6796648\",\"pathway\":\"TP53 Regulates Transcription of DNA Repair Genes\"},{\"pathwayId\":\"R-HSA-6803207\",\"pathway\":\"TP53 Regulates Transcription of Caspase Activators and Caspases\"},{\"pathwayId\":\"R-HSA-5628897\",\"pathway\":\"TP53 Regulates Metabolic Genes\"},{\"pathwayId\":\"R-HSA-6804115\",\"pathway\":\"TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain\"},{\"pathwayId\":\"R-HSA-69473\",\"pathway\":\"G2/M DNA damage checkpoint\"},{\"pathwayId\":\"R-HSA-6803211\",\"pathway\":\"TP53 Regulates Transcription of Death Receptors and Ligands\"},{\"pathwayId\":\"R-HSA-2559584\",\"pathway\":\"Formation of Senescence-Associated Heterochromatin Foci (SAHF)\"},{\"pathwayId\":\"R-HSA-6804114\",\"pathway\":\"TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest\"},{\"pathwayId\":\"R-HSA-6804758\",\"pathway\":\"Regulation of TP53 Activity through Acetylation\"},{\"pathwayId\":\"R-HSA-8853884\",\"pathway\":\"Transcriptional Regulation by VENTX\"},{\"pathwayId\":\"R-HSA-6804116\",\"pathway\":\"TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest\"},{\"pathwayId\":\"R-HSA-6804759\",\"pathway\":\"Regulation of TP53 Activity through Association with Co-factors\"},{\"pathwayId\":\"R-HSA-8943724\",\"pathway\":\"Regulation of PTEN gene transcription\"},{\"pathwayId\":\"R-HSA-6785807\",\"pathway\":\"Interleukin-4 and Interleukin-13 signaling\"},{\"pathwayId\":\"R-HSA-8852276\",\"pathway\":\"The role of GTSE1 in G2/M progression after G2 checkpoint\"},{\"pathwayId\":\"R-HSA-1912408\",\"pathway\":\"Pre-NOTCH Transcription and Translation\"},{\"pathwayId\":\"R-HSA-6811555\",\"pathway\":\"PI5P Regulates TP53 Acetylation\"},{\"pathwayId\":\"R-HSA-5620971\",\"pathway\":\"Pyroptosis\"},{\"pathwayId\":\"R-HSA-6804757\",\"pathway\":\"Regulation of TP53 Degradation\"},{\"pathwayId\":\"R-HSA-8941855\",\"pathway\":\"RUNX3 regulates CDKN1A transcription\"},{\"pathwayId\":\"R-HSA-9723905\",\"pathway\":\"Loss of function of TP53 in cancer due to loss of tetramerization ability\"},{\"pathwayId\":\"R-HSA-69481\",\"pathway\":\"G2/M Checkpoints\"},{\"pathwayId\":\"R-HSA-5689880\",\"pathway\":\"Ub-specific processing proteases\"},{\"pathwayId\":\"R-HSA-6803205\",\"pathway\":\"TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain\"},{\"pathwayId\":\"R-HSA-6804760\",\"pathway\":\"Regulation of TP53 Activity through Methylation\"},{\"pathwayId\":\"R-HSA-6804754\",\"pathway\":\"Regulation of TP53 Expression\"},{\"pathwayId\":\"R-HSA-111448\",\"pathway\":\"Activation of NOXA and translocation to mitochondria\"},{\"pathwayId\":\"R-HSA-6803204\",\"pathway\":\"TP53 Regulates Transcription of Genes Involved in Cytochrome C Release\"},{\"pathwayId\":\"R-HSA-390471\",\"pathway\":\"Association of TriC/CCT with target proteins during biosynthesis\"},{\"pathwayId\":\"R-HSA-69541\",\"pathway\":\"Stabilization of p53\"},{\"pathwayId\":\"R-HSA-983231\",\"pathway\":\"Factors involved in megakaryocyte development and platelet production\"},{\"pathwayId\":\"R-HSA-69895\",\"pathway\":\"Transcriptional  activation of  cell cycle inhibitor p21 \"},{\"pathwayId\":\"R-HSA-5693565\",\"pathway\":\"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks\"},{\"pathwayId\":\"R-HSA-5689896\",\"pathway\":\"Ovarian tumor domain proteases\"},{\"pathwayId\":\"R-HSA-2559585\",\"pathway\":\"Oncogene Induced Senescence\"},{\"pathwayId\":\"R-HSA-139915\",\"pathway\":\"Activation of PUMA and translocation to mitochondria\"}]}},{\"target\":{\"id\":\"ENSG00000091831\",\"approvedSymbol\":\"ESR1\",\"pathways\":[{\"pathwayId\":\"R-HSA-9018519\",\"pathway\":\"Estrogen-dependent gene expression\"},{\"pathwayId\":\"R-HSA-9009391\",\"pathway\":\"Extra-nuclear estrogen signaling\"},{\"pathwayId\":\"R-HSA-6811558\",\"pathway\":\"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling\"},{\"pathwayId\":\"R-HSA-4090294\",\"pathway\":\"SUMOylation of intracellular receptors\"},{\"pathwayId\":\"R-HSA-8939902\",\"pathway\":\"Regulation of RUNX2 expression and activity\"},{\"pathwayId\":\"R-HSA-2219530\",\"pathway\":\"Constitutive Signaling by Aberrant PI3K in Cancer\"},{\"pathwayId\":\"R-HSA-383280\",\"pathway\":\"Nuclear Receptor transcription pathway\"},{\"pathwayId\":\"R-HSA-8931987\",\"pathway\":\"RUNX1 regulates estrogen receptor mediated transcription\"},{\"pathwayId\":\"R-HSA-1251985\",\"pathway\":\"Nuclear signaling by ERBB4\"},{\"pathwayId\":\"R-HSA-5689896\",\"pathway\":\"Ovarian tumor domain proteases\"},{\"pathwayId\":\"R-HSA-8866910\",\"pathway\":\"TFAP2 (AP-2) family regulates transcription of growth factors and their receptors\"},{\"pathwayId\":\"R-HSA-8939211\",\"pathway\":\"ESR-mediated signaling\"},{\"pathwayId\":\"R-HSA-1257604\",\"pathway\":\"PIP3 activates AKT signaling\"},{\"pathwayId\":\"R-HSA-8939256\",\"pathway\":\"RUNX1 regulates transcription of genes involved in WNT signaling\"}]}},{\"target\":{\"id\":\"ENSG00000083093\",\"approvedSymbol\":\"PALB2\",\"pathways\":[{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-8951664\",\"pathway\":\"Neddylation\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-9755511\",\"pathway\":\"KEAP1-NFE2L2 pathway\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"}]}},{\"target\":{\"id\":\"ENSG00000141736\",\"approvedSymbol\":\"ERBB2\",\"pathways\":[{\"pathwayId\":\"R-HSA-6811558\",\"pathway\":\"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling\"},{\"pathwayId\":\"R-HSA-9665233\",\"pathway\":\"Resistance of ERBB2 KD mutants to trastuzumab\"},{\"pathwayId\":\"R-HSA-8847993\",\"pathway\":\"ERBB2 Activates PTK6 Signaling\"},{\"pathwayId\":\"R-HSA-9665737\",\"pathway\":\"Drug resistance in ERBB2 TMD/JMD mutants\"},{\"pathwayId\":\"R-HSA-8863795\",\"pathway\":\"Downregulation of ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-9652282\",\"pathway\":\"Drug-mediated inhibition of ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-9665251\",\"pathway\":\"Resistance of ERBB2 KD mutants to lapatinib\"},{\"pathwayId\":\"R-HSA-9665245\",\"pathway\":\"Resistance of ERBB2 KD mutants to tesevatinib\"},{\"pathwayId\":\"R-HSA-5673001\",\"pathway\":\"RAF/MAP kinase cascade\"},{\"pathwayId\":\"R-HSA-1227986\",\"pathway\":\"Signaling by ERBB2\"},{\"pathwayId\":\"R-HSA-9665246\",\"pathway\":\"Resistance of ERBB2 KD mutants to neratinib\"},{\"pathwayId\":\"R-HSA-1963640\",\"pathway\":\"GRB2 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-9664565\",\"pathway\":\"Signaling by ERBB2 KD Mutants\"},{\"pathwayId\":\"R-HSA-8866910\",\"pathway\":\"TFAP2 (AP-2) family regulates transcription of growth factors and their receptors\"},{\"pathwayId\":\"R-HSA-6785631\",\"pathway\":\"ERBB2 Regulates Cell Motility\"},{\"pathwayId\":\"R-HSA-1257604\",\"pathway\":\"PIP3 activates AKT signaling\"},{\"pathwayId\":\"R-HSA-1251932\",\"pathway\":\"PLCG1 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-1963642\",\"pathway\":\"PI3K events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-1250196\",\"pathway\":\"SHC1 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-2219530\",\"pathway\":\"Constitutive Signaling by Aberrant PI3K in Cancer\"},{\"pathwayId\":\"R-HSA-9634285\",\"pathway\":\"Constitutive Signaling by Overexpressed ERBB2\"},{\"pathwayId\":\"R-HSA-9665250\",\"pathway\":\"Resistance of ERBB2 KD mutants to AEE788\"},{\"pathwayId\":\"R-HSA-1358803\",\"pathway\":\"Downregulation of ERBB2:ERBB3 signaling\"},{\"pathwayId\":\"R-HSA-1306955\",\"pathway\":\"GRB7 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-9665348\",\"pathway\":\"Signaling by ERBB2 ECD mutants\"},{\"pathwayId\":\"R-HSA-9665244\",\"pathway\":\"Resistance of ERBB2 KD mutants to sapitinib\"},{\"pathwayId\":\"R-HSA-9665249\",\"pathway\":\"Resistance of ERBB2 KD mutants to afatinib\"},{\"pathwayId\":\"R-HSA-9665686\",\"pathway\":\"Signaling by ERBB2 TMD/JMD mutants\"},{\"pathwayId\":\"R-HSA-416572\",\"pathway\":\"Sema4D induced cell migration and growth-cone collapse\"},{\"pathwayId\":\"R-HSA-9665247\",\"pathway\":\"Resistance of ERBB2 KD mutants to osimertinib\"}]}},{\"target\":{\"id\":\"ENSG00000039068\",\"approvedSymbol\":\"CDH1\",\"pathways\":[{\"pathwayId\":\"R-HSA-351906\",\"pathway\":\"Apoptotic cleavage of cell adhesion  proteins\"},{\"pathwayId\":\"R-HSA-198933\",\"pathway\":\"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell\"},{\"pathwayId\":\"R-HSA-418990\",\"pathway\":\"Adherens junctions interactions\"},{\"pathwayId\":\"R-HSA-9823730\",\"pathway\":\"Formation of definitive endoderm\"},{\"pathwayId\":\"R-HSA-5626467\",\"pathway\":\"RHO GTPases activate IQGAPs\"},{\"pathwayId\":\"R-HSA-8876493\",\"pathway\":\"InlA-mediated entry of Listeria monocytogenes into host cells\"},{\"pathwayId\":\"R-HSA-216083\",\"pathway\":\"Integrin cell surface interactions\"},{\"pathwayId\":\"R-HSA-1474228\",\"pathway\":\"Degradation of the extracellular matrix\"},{\"pathwayId\":\"R-HSA-9758919\",\"pathway\":\"Epithelial-Mesenchymal Transition (EMT) during gastrulation\"}]}},{\"target\":{\"id\":\"ENSG00000142208\",\"approvedSymbol\":\"AKT1\",\"pathways\":[{\"pathwayId\":\"R-HSA-9009391\",\"pathway\":\"Extra-nuclear estrogen signaling\"},{\"pathwayId\":\"R-HSA-6811558\",\"pathway\":\"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling\"},{\"pathwayId\":\"R-HSA-9607240\",\"pathway\":\"FLT3 Signaling\"},{\"pathwayId\":\"R-HSA-8849469\",\"pathway\":\"PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1\"},{\"pathwayId\":\"R-HSA-5628897\",\"pathway\":\"TP53 Regulates Metabolic Genes\"},{\"pathwayId\":\"R-HSA-354192\",\"pathway\":\"Integrin signaling\"},{\"pathwayId\":\"R-HSA-165159\",\"pathway\":\"MTOR signalling\"},{\"pathwayId\":\"R-HSA-69656\",\"pathway\":\"Cyclin A:Cdk2-associated events at S phase entry\"},{\"pathwayId\":\"R-HSA-3769402\",\"pathway\":\"Deactivation of the beta-catenin transactivating complex\"},{\"pathwayId\":\"R-HSA-9614399\",\"pathway\":\"Regulation of localization of FOXO transcription factors\"},{\"pathwayId\":\"R-HSA-389513\",\"pathway\":\"CTLA4 inhibitory signaling\"},{\"pathwayId\":\"R-HSA-198693\",\"pathway\":\"AKT phosphorylates targets in the nucleus\"},{\"pathwayId\":\"R-HSA-69202\",\"pathway\":\"Cyclin E associated events during G1/S transition \"},{\"pathwayId\":\"R-HSA-6804758\",\"pathway\":\"Regulation of TP53 Activity through Acetylation\"},{\"pathwayId\":\"R-HSA-1445148\",\"pathway\":\"Translocation of SLC2A4 (GLUT4) to the plasma membrane\"},{\"pathwayId\":\"R-HSA-5674400\",\"pathway\":\"Constitutive Signaling by AKT1 E17K in Cancer\"},{\"pathwayId\":\"R-HSA-5218920\",\"pathway\":\"VEGFR2 mediated vascular permeability\"},{\"pathwayId\":\"R-HSA-6804759\",\"pathway\":\"Regulation of TP53 Activity through Association with Co-factors\"},{\"pathwayId\":\"R-HSA-6785807\",\"pathway\":\"Interleukin-4 and Interleukin-13 signaling\"},{\"pathwayId\":\"R-HSA-1257604\",\"pathway\":\"PIP3 activates AKT signaling\"},{\"pathwayId\":\"R-HSA-111447\",\"pathway\":\"Activation of BAD and translocation to mitochondria \"},{\"pathwayId\":\"R-HSA-198323\",\"pathway\":\"AKT phosphorylates targets in the cytosol\"},{\"pathwayId\":\"R-HSA-8948751\",\"pathway\":\"Regulation of PTEN stability and activity\"},{\"pathwayId\":\"R-HSA-6804757\",\"pathway\":\"Regulation of TP53 Degradation\"},{\"pathwayId\":\"R-HSA-9755779\",\"pathway\":\"SARS-CoV-2 targets host intracellular signalling and regulatory pathways\"},{\"pathwayId\":\"R-HSA-9604323\",\"pathway\":\"Negative regulation of NOTCH4 signaling\"},{\"pathwayId\":\"R-HSA-8941332\",\"pathway\":\"RUNX2 regulates genes involved in cell migration\"},{\"pathwayId\":\"R-HSA-8876198\",\"pathway\":\"RAB GEFs exchange GTP for GDP on RABs\"},{\"pathwayId\":\"R-HSA-450604\",\"pathway\":\"KSRP (KHSRP) binds and destabilizes mRNA\"},{\"pathwayId\":\"R-HSA-211163\",\"pathway\":\"AKT-mediated inactivation of FOXO1A\"},{\"pathwayId\":\"R-HSA-9755511\",\"pathway\":\"KEAP1-NFE2L2 pathway\"},{\"pathwayId\":\"R-HSA-389357\",\"pathway\":\"CD28 dependent PI3K/Akt signaling\"},{\"pathwayId\":\"R-HSA-199418\",\"pathway\":\"Negative regulation of the PI3K/AKT network\"},{\"pathwayId\":\"R-HSA-1358803\",\"pathway\":\"Downregulation of ERBB2:ERBB3 signaling\"},{\"pathwayId\":\"R-HSA-450385\",\"pathway\":\"Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA\"},{\"pathwayId\":\"R-HSA-392451\",\"pathway\":\"G beta:gamma signalling through PI3Kgamma\"},{\"pathwayId\":\"R-HSA-9634638\",\"pathway\":\"Estrogen-dependent nuclear events downstream of ESR-membrane signaling\"},{\"pathwayId\":\"R-HSA-1474151\",\"pathway\":\"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation\"},{\"pathwayId\":\"R-HSA-203615\",\"pathway\":\"eNOS activation\"}]}},{\"target\":{\"id\":\"ENSG00000136492\",\"approvedSymbol\":\"BRIP1\",\"pathways\":[{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-6804756\",\"pathway\":\"Regulation of TP53 Activity through Phosphorylation\"},{\"pathwayId\":\"R-HSA-5693616\",\"pathway\":\"Presynaptic phase of homologous DNA pairing and strand exchange\"},{\"pathwayId\":\"R-HSA-9709570\",\"pathway\":\"Impaired BRCA2 binding to RAD51\"},{\"pathwayId\":\"R-HSA-5693607\",\"pathway\":\"Processing of DNA double-strand break ends\"},{\"pathwayId\":\"R-HSA-2564830\",\"pathway\":\"Cytosolic iron-sulfur cluster assembly\"},{\"pathwayId\":\"R-HSA-69473\",\"pathway\":\"G2/M DNA damage checkpoint\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5685938\",\"pathway\":\"HDR through Single Strand Annealing (SSA)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"}]}},{\"target\":{\"id\":\"ENSG00000149311\",\"approvedSymbol\":\"ATM\",\"pathways\":[{\"pathwayId\":\"R-HSA-2559586\",\"pathway\":\"DNA Damage/Telomere Stress Induced Senescence\"},{\"pathwayId\":\"R-HSA-5693616\",\"pathway\":\"Presynaptic phase of homologous DNA pairing and strand exchange\"},{\"pathwayId\":\"R-HSA-6804756\",\"pathway\":\"Regulation of TP53 Activity through Phosphorylation\"},{\"pathwayId\":\"R-HSA-9664873\",\"pathway\":\"Pexophagy\"},{\"pathwayId\":\"R-HSA-349425\",\"pathway\":\"Autodegradation of the E3 ubiquitin ligase COP1\"},{\"pathwayId\":\"R-HSA-6796648\",\"pathway\":\"TP53 Regulates Transcription of DNA Repair Genes\"},{\"pathwayId\":\"R-HSA-6803207\",\"pathway\":\"TP53 Regulates Transcription of Caspase Activators and Caspases\"},{\"pathwayId\":\"R-HSA-5693607\",\"pathway\":\"Processing of DNA double-strand break ends\"},{\"pathwayId\":\"R-HSA-69473\",\"pathway\":\"G2/M DNA damage checkpoint\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5685938\",\"pathway\":\"HDR through Single Strand Annealing (SSA)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-6804757\",\"pathway\":\"Regulation of TP53 Degradation\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"},{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-5693548\",\"pathway\":\"Sensing of DNA Double Strand Breaks\"},{\"pathwayId\":\"R-HSA-6804760\",\"pathway\":\"Regulation of TP53 Activity through Methylation\"},{\"pathwayId\":\"R-HSA-9709570\",\"pathway\":\"Impaired BRCA2 binding to RAD51\"},{\"pathwayId\":\"R-HSA-3371453\",\"pathway\":\"Regulation of HSF1-mediated heat shock response\"},{\"pathwayId\":\"R-HSA-6803204\",\"pathway\":\"TP53 Regulates Transcription of Genes Involved in Cytochrome C Release\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-69541\",\"pathway\":\"Stabilization of p53\"},{\"pathwayId\":\"R-HSA-5693571\",\"pathway\":\"Nonhomologous End-Joining (NHEJ)\"},{\"pathwayId\":\"R-HSA-912446\",\"pathway\":\"Meiotic recombination\"},{\"pathwayId\":\"R-HSA-5693565\",\"pathway\":\"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks\"}]}},{\"target\":{\"id\":\"ENSG00000171862\",\"approvedSymbol\":\"PTEN\",\"pathways\":[{\"pathwayId\":\"R-HSA-202424\",\"pathway\":\"Downstream TCR signaling\"},{\"pathwayId\":\"R-HSA-1855204\",\"pathway\":\"Synthesis of IP3 and IP4 in the cytosol\"},{\"pathwayId\":\"R-HSA-5689880\",\"pathway\":\"Ub-specific processing proteases\"},{\"pathwayId\":\"R-HSA-8986944\",\"pathway\":\"Transcriptional Regulation by MECP2\"},{\"pathwayId\":\"R-HSA-8943724\",\"pathway\":\"Regulation of PTEN gene transcription\"},{\"pathwayId\":\"R-HSA-1660499\",\"pathway\":\"Synthesis of PIPs at the plasma membrane\"},{\"pathwayId\":\"R-HSA-5689896\",\"pathway\":\"Ovarian tumor domain proteases\"},{\"pathwayId\":\"R-HSA-8948747\",\"pathway\":\"Regulation of PTEN localization\"},{\"pathwayId\":\"R-HSA-5628897\",\"pathway\":\"TP53 Regulates Metabolic Genes\"},{\"pathwayId\":\"R-HSA-5674404\",\"pathway\":\"PTEN Loss of Function in Cancer\"},{\"pathwayId\":\"R-HSA-8948751\",\"pathway\":\"Regulation of PTEN stability and activity\"},{\"pathwayId\":\"R-HSA-8943723\",\"pathway\":\"Regulation of PTEN mRNA translation\"},{\"pathwayId\":\"R-HSA-199418\",\"pathway\":\"Negative regulation of the PI3K/AKT network\"}]}},{\"target\":{\"id\":\"ENSG00000108384\",\"approvedSymbol\":\"RAD51C\",\"pathways\":[{\"pathwayId\":\"R-HSA-983231\",\"pathway\":\"Factors involved in megakaryocyte development and platelet production\"},{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-912446\",\"pathway\":\"Meiotic recombination\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-5693616\",\"pathway\":\"Presynaptic phase of homologous DNA pairing and strand exchange\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"}]}},{\"target\":{\"id\":\"ENSG00000185379\",\"approvedSymbol\":\"RAD51D\",\"pathways\":[{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-5693616\",\"pathway\":\"Presynaptic phase of homologous DNA pairing and strand exchange\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-6796648\",\"pathway\":\"TP53 Regulates Transcription of DNA Repair Genes\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"}]}},{\"target\":{\"id\":\"ENSG00000105810\",\"approvedSymbol\":\"CDK6\",\"pathways\":[{\"pathwayId\":\"R-HSA-8934593\",\"pathway\":\"Regulation of RUNX1 Expression and Activity\"},{\"pathwayId\":\"R-HSA-9630794\",\"pathway\":\"Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6\"},{\"pathwayId\":\"R-HSA-2559580\",\"pathway\":\"Oxidative Stress Induced Senescence\"},{\"pathwayId\":\"R-HSA-2559585\",\"pathway\":\"Oncogene Induced Senescence\"},{\"pathwayId\":\"R-HSA-9754119\",\"pathway\":\"Drug-mediated inhibition of CDK4/CDK6 activity\"},{\"pathwayId\":\"R-HSA-69231\",\"pathway\":\"Cyclin D associated events in G1\"},{\"pathwayId\":\"R-HSA-9661069\",\"pathway\":\"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)\"},{\"pathwayId\":\"R-HSA-9632700\",\"pathway\":\"Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6\"},{\"pathwayId\":\"R-HSA-2559582\",\"pathway\":\"Senescence-Associated Secretory Phenotype (SASP)\"}]}},{\"target\":{\"id\":\"ENSG00000138376\",\"approvedSymbol\":\"BARD1\",\"pathways\":[{\"pathwayId\":\"R-HSA-5693568\",\"pathway\":\"Resolution of D-loop Structures through Holliday Junction Intermediates\"},{\"pathwayId\":\"R-HSA-5693579\",\"pathway\":\"Homologous DNA Pairing and Strand Exchange\"},{\"pathwayId\":\"R-HSA-9704646\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function\"},{\"pathwayId\":\"R-HSA-6804756\",\"pathway\":\"Regulation of TP53 Activity through Phosphorylation\"},{\"pathwayId\":\"R-HSA-5693616\",\"pathway\":\"Presynaptic phase of homologous DNA pairing and strand exchange\"},{\"pathwayId\":\"R-HSA-9663199\",\"pathway\":\"Defective DNA double strand break response due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9709570\",\"pathway\":\"Impaired BRCA2 binding to RAD51\"},{\"pathwayId\":\"R-HSA-5689901\",\"pathway\":\"Metalloprotease DUBs\"},{\"pathwayId\":\"R-HSA-5693607\",\"pathway\":\"Processing of DNA double-strand break ends\"},{\"pathwayId\":\"R-HSA-69473\",\"pathway\":\"G2/M DNA damage checkpoint\"},{\"pathwayId\":\"R-HSA-5693554\",\"pathway\":\"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)\"},{\"pathwayId\":\"R-HSA-5693571\",\"pathway\":\"Nonhomologous End-Joining (NHEJ)\"},{\"pathwayId\":\"R-HSA-9699150\",\"pathway\":\"Defective DNA double strand break response due to BARD1 loss of function\"},{\"pathwayId\":\"R-HSA-9709603\",\"pathway\":\"Impaired BRCA2 binding to PALB2\"},{\"pathwayId\":\"R-HSA-5689603\",\"pathway\":\"UCH proteinases\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5693565\",\"pathway\":\"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks\"},{\"pathwayId\":\"R-HSA-5685938\",\"pathway\":\"HDR through Single Strand Annealing (SSA)\"},{\"pathwayId\":\"R-HSA-9701192\",\"pathway\":\"Defective homologous recombination repair (HRR) due to BRCA1 loss of function\"},{\"pathwayId\":\"R-HSA-9704331\",\"pathway\":\"Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function\"}]}},{\"target\":{\"id\":\"ENSG00000178568\",\"approvedSymbol\":\"ERBB4\",\"pathways\":[{\"pathwayId\":\"R-HSA-9018519\",\"pathway\":\"Estrogen-dependent gene expression\"},{\"pathwayId\":\"R-HSA-6811558\",\"pathway\":\"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling\"},{\"pathwayId\":\"R-HSA-1963642\",\"pathway\":\"PI3K events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-1250196\",\"pathway\":\"SHC1 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-8847993\",\"pathway\":\"ERBB2 Activates PTK6 Signaling\"},{\"pathwayId\":\"R-HSA-2219530\",\"pathway\":\"Constitutive Signaling by Aberrant PI3K in Cancer\"},{\"pathwayId\":\"R-HSA-8863795\",\"pathway\":\"Downregulation of ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-5673001\",\"pathway\":\"RAF/MAP kinase cascade\"},{\"pathwayId\":\"R-HSA-1227986\",\"pathway\":\"Signaling by ERBB2\"},{\"pathwayId\":\"R-HSA-1253288\",\"pathway\":\"Downregulation of ERBB4 signaling\"},{\"pathwayId\":\"R-HSA-1251985\",\"pathway\":\"Nuclear signaling by ERBB4\"},{\"pathwayId\":\"R-HSA-1963640\",\"pathway\":\"GRB2 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-9664565\",\"pathway\":\"Signaling by ERBB2 KD Mutants\"},{\"pathwayId\":\"R-HSA-1250342\",\"pathway\":\"PI3K events in ERBB4 signaling\"},{\"pathwayId\":\"R-HSA-6785631\",\"pathway\":\"ERBB2 Regulates Cell Motility\"},{\"pathwayId\":\"R-HSA-1236394\",\"pathway\":\"Signaling by ERBB4\"},{\"pathwayId\":\"R-HSA-1257604\",\"pathway\":\"PIP3 activates AKT signaling\"},{\"pathwayId\":\"R-HSA-9665686\",\"pathway\":\"Signaling by ERBB2 TMD/JMD mutants\"},{\"pathwayId\":\"R-HSA-1250347\",\"pathway\":\"SHC1 events in ERBB4 signaling\"},{\"pathwayId\":\"R-HSA-9620244\",\"pathway\":\"Long-term potentiation\"}]}},{\"target\":{\"id\":\"ENSG00000095015\",\"approvedSymbol\":\"MAP3K1\",\"pathways\":[{\"pathwayId\":\"R-HSA-975138\",\"pathway\":\"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation\"},{\"pathwayId\":\"R-HSA-166058\",\"pathway\":\"MyD88:MAL(TIRAP) cascade initiated on plasma membrane\"},{\"pathwayId\":\"R-HSA-2871796\",\"pathway\":\"FCERI mediated MAPK activation\"},{\"pathwayId\":\"R-HSA-975871\",\"pathway\":\"MyD88 cascade initiated on plasma membrane\"},{\"pathwayId\":\"R-HSA-933542\",\"pathway\":\"TRAF6 mediated NF-kB activation\"}]}},{\"target\":{\"id\":\"ENSG00000146648\",\"approvedSymbol\":\"EGFR\",\"pathways\":[{\"pathwayId\":\"R-HSA-9009391\",\"pathway\":\"Extra-nuclear estrogen signaling\"},{\"pathwayId\":\"R-HSA-6811558\",\"pathway\":\"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling\"},{\"pathwayId\":\"R-HSA-180336\",\"pathway\":\"SHC1 events in EGFR signaling\"},{\"pathwayId\":\"R-HSA-8847993\",\"pathway\":\"ERBB2 Activates PTK6 Signaling\"},{\"pathwayId\":\"R-HSA-177929\",\"pathway\":\"Signaling by EGFR\"},{\"pathwayId\":\"R-HSA-5637810\",\"pathway\":\"Constitutive Signaling by EGFRvIII\"},{\"pathwayId\":\"R-HSA-182971\",\"pathway\":\"EGFR downregulation\"},{\"pathwayId\":\"R-HSA-8863795\",\"pathway\":\"Downregulation of ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-8857538\",\"pathway\":\"PTK6 promotes HIF1A stabilization\"},{\"pathwayId\":\"R-HSA-8856825\",\"pathway\":\"Cargo recognition for clathrin-mediated endocytosis\"},{\"pathwayId\":\"R-HSA-5673001\",\"pathway\":\"RAF/MAP kinase cascade\"},{\"pathwayId\":\"R-HSA-1227986\",\"pathway\":\"Signaling by ERBB2\"},{\"pathwayId\":\"R-HSA-2179392\",\"pathway\":\"EGFR Transactivation by Gastrin\"},{\"pathwayId\":\"R-HSA-1963640\",\"pathway\":\"GRB2 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-180292\",\"pathway\":\"GAB1 signalosome\"},{\"pathwayId\":\"R-HSA-9664565\",\"pathway\":\"Signaling by ERBB2 KD Mutants\"},{\"pathwayId\":\"R-HSA-445144\",\"pathway\":\"Signal transduction by L1\"},{\"pathwayId\":\"R-HSA-1236382\",\"pathway\":\"Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants\"},{\"pathwayId\":\"R-HSA-8866910\",\"pathway\":\"TFAP2 (AP-2) family regulates transcription of growth factors and their receptors\"},{\"pathwayId\":\"R-HSA-6785631\",\"pathway\":\"ERBB2 Regulates Cell Motility\"},{\"pathwayId\":\"R-HSA-9609690\",\"pathway\":\"HCMV Early Events\"},{\"pathwayId\":\"R-HSA-1257604\",\"pathway\":\"PIP3 activates AKT signaling\"},{\"pathwayId\":\"R-HSA-9013507\",\"pathway\":\"NOTCH3 Activation and Transmission of Signal to the Nucleus\"},{\"pathwayId\":\"R-HSA-8856828\",\"pathway\":\"Clathrin-mediated endocytosis\"},{\"pathwayId\":\"R-HSA-179812\",\"pathway\":\"GRB2 events in EGFR signaling\"},{\"pathwayId\":\"R-HSA-1251932\",\"pathway\":\"PLCG1 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-212718\",\"pathway\":\"EGFR interacts with phospholipase C-gamma\"},{\"pathwayId\":\"R-HSA-1963642\",\"pathway\":\"PI3K events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-1250196\",\"pathway\":\"SHC1 events in ERBB2 signaling\"},{\"pathwayId\":\"R-HSA-2219530\",\"pathway\":\"Constitutive Signaling by Aberrant PI3K in Cancer\"},{\"pathwayId\":\"R-HSA-5638303\",\"pathway\":\"Inhibition of Signaling by Overexpressed EGFR\"},{\"pathwayId\":\"R-HSA-9665348\",\"pathway\":\"Signaling by ERBB2 ECD mutants\"},{\"pathwayId\":\"R-HSA-1236394\",\"pathway\":\"Signaling by ERBB4\"},{\"pathwayId\":\"R-HSA-9634638\",\"pathway\":\"Estrogen-dependent nuclear events downstream of ESR-membrane signaling\"},{\"pathwayId\":\"R-HSA-9665686\",\"pathway\":\"Signaling by ERBB2 TMD/JMD mutants\"}]}},{\"target\":{\"id\":\"ENSG00000062822\",\"approvedSymbol\":\"POLD1\",\"pathways\":[{\"pathwayId\":\"R-HSA-6782135\",\"pathway\":\"Dual incision in TC-NER\"},{\"pathwayId\":\"R-HSA-6782210\",\"pathway\":\"Gap-filling DNA repair synthesis and ligation in TC-NER\"},{\"pathwayId\":\"R-HSA-174411\",\"pathway\":\"Polymerase switching on the C-strand of the telomere\"},{\"pathwayId\":\"R-HSA-110314\",\"pathway\":\"Recognition of DNA damage by PCNA-containing replication complex\"},{\"pathwayId\":\"R-HSA-5358565\",\"pathway\":\"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)\"},{\"pathwayId\":\"R-HSA-5696397\",\"pathway\":\"Gap-filling DNA repair synthesis and ligation in GG-NER\"},{\"pathwayId\":\"R-HSA-5696400\",\"pathway\":\"Dual Incision in GG-NER\"},{\"pathwayId\":\"R-HSA-69091\",\"pathway\":\"Polymerase switching\"},{\"pathwayId\":\"R-HSA-2564830\",\"pathway\":\"Cytosolic iron-sulfur cluster assembly\"},{\"pathwayId\":\"R-HSA-5358606\",\"pathway\":\"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)\"},{\"pathwayId\":\"R-HSA-174417\",\"pathway\":\"Telomere C-strand (Lagging Strand) Synthesis\"},{\"pathwayId\":\"R-HSA-69183\",\"pathway\":\"Processive synthesis on the lagging strand\"},{\"pathwayId\":\"R-HSA-5656169\",\"pathway\":\"Termination of translesion DNA synthesis\"},{\"pathwayId\":\"R-HSA-174414\",\"pathway\":\"Processive synthesis on the C-strand of the telomere\"},{\"pathwayId\":\"R-HSA-69166\",\"pathway\":\"Removal of the Flap Intermediate\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5651801\",\"pathway\":\"PCNA-Dependent Long Patch Base Excision Repair\"},{\"pathwayId\":\"R-HSA-174437\",\"pathway\":\"Removal of the Flap Intermediate from the C-strand\"}]}},{\"target\":{\"id\":\"ENSG00000107485\",\"approvedSymbol\":\"GATA3\",\"pathways\":[{\"pathwayId\":\"R-HSA-983231\",\"pathway\":\"Factors involved in megakaryocyte development and platelet production\"},{\"pathwayId\":\"R-HSA-9018519\",\"pathway\":\"Estrogen-dependent gene expression\"},{\"pathwayId\":\"R-HSA-5689880\",\"pathway\":\"Ub-specific processing proteases\"},{\"pathwayId\":\"R-HSA-8939236\",\"pathway\":\"RUNX1 regulates transcription of genes involved in differentiation of HSCs\"},{\"pathwayId\":\"R-HSA-6785807\",\"pathway\":\"Interleukin-4 and Interleukin-13 signaling\"}]}},{\"target\":{\"id\":\"ENSG00000135111\",\"approvedSymbol\":\"TBX3\",\"pathways\":[]}},{\"target\":{\"id\":\"ENSG00000177084\",\"approvedSymbol\":\"POLE\",\"pathways\":[{\"pathwayId\":\"R-HSA-6782135\",\"pathway\":\"Dual incision in TC-NER\"},{\"pathwayId\":\"R-HSA-5656169\",\"pathway\":\"Termination of translesion DNA synthesis\"},{\"pathwayId\":\"R-HSA-6782210\",\"pathway\":\"Gap-filling DNA repair synthesis and ligation in TC-NER\"},{\"pathwayId\":\"R-HSA-110314\",\"pathway\":\"Recognition of DNA damage by PCNA-containing replication complex\"},{\"pathwayId\":\"R-HSA-5696397\",\"pathway\":\"Gap-filling DNA repair synthesis and ligation in GG-NER\"},{\"pathwayId\":\"R-HSA-5685942\",\"pathway\":\"HDR through Homologous Recombination (HRR)\"},{\"pathwayId\":\"R-HSA-5696400\",\"pathway\":\"Dual Incision in GG-NER\"},{\"pathwayId\":\"R-HSA-5651801\",\"pathway\":\"PCNA-Dependent Long Patch Base Excision Repair\"},{\"pathwayId\":\"R-HSA-68952\",\"pathway\":\"DNA replication initiation\"},{\"pathwayId\":\"R-HSA-68962\",\"pathway\":\"Activation of the pre-replicative complex\"}]}},{\"target\":{\"id\":\"ENSG00000135446\",\"approvedSymbol\":\"CDK4\",\"pathways\":[{\"pathwayId\":\"R-HSA-381340\",\"pathway\":\"Transcriptional regulation of white adipocyte differentiation\"},{\"pathwayId\":\"R-HSA-9630794\",\"pathway\":\"Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6\"},{\"pathwayId\":\"R-HSA-75815\",\"pathway\":\"Ubiquitin-dependent degradation of Cyclin D\"},{\"pathwayId\":\"R-HSA-2559580\",\"pathway\":\"Oxidative Stress Induced Senescence\"},{\"pathwayId\":\"R-HSA-8878166\",\"pathway\":\"Transcriptional regulation by RUNX2\"},{\"pathwayId\":\"R-HSA-187577\",\"pathway\":\"SCF(Skp2)-mediated degradation of p27/p21\"},{\"pathwayId\":\"R-HSA-9632697\",\"pathway\":\"Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4\"},{\"pathwayId\":\"R-HSA-9754119\",\"pathway\":\"Drug-mediated inhibition of CDK4/CDK6 activity\"},{\"pathwayId\":\"R-HSA-9632700\",\"pathway\":\"Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6\"},{\"pathwayId\":\"R-HSA-8849470\",\"pathway\":\"PTK6 Regulates Cell Cycle\"},{\"pathwayId\":\"R-HSA-2559582\",\"pathway\":\"Senescence-Associated Secretory Phenotype (SASP)\"},{\"pathwayId\":\"R-HSA-912446\",\"pathway\":\"Meiotic recombination\"},{\"pathwayId\":\"R-HSA-3214858\",\"pathway\":\"RMTs methylate histone arginines\"},{\"pathwayId\":\"R-HSA-9616222\",\"pathway\":\"Transcriptional regulation of granulopoiesis\"},{\"pathwayId\":\"R-HSA-9630791\",\"pathway\":\"Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4\"},{\"pathwayId\":\"R-HSA-2559585\",\"pathway\":\"Oncogene Induced Senescence\"},{\"pathwayId\":\"R-HSA-69231\",\"pathway\":\"Cyclin D associated events in G1\"},{\"pathwayId\":\"R-HSA-9661069\",\"pathway\":\"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)\"}]}}]}}}]}}}\n",
      "query generated_query {\n",
      "  search(queryString: \"BRCA1\", entityNames: \"target\", page: {index: 0, size: 1}) {\n",
      "    hits {\n",
      "      id\n",
      "      name\n",
      "      entity\n",
      "      object {\n",
      "        ... on Target {\n",
      "          associatedDiseases(page: { index: 0, size: 2 }) {\n",
      "            rows {\n",
      "              score\n",
      "              disease {\n",
      "                name\n",
      "              }\n",
      "            }\n",
      "          }\n",
      "        }\n",
      "      }\n",
      "    }\n",
      "  }\n",
      "}\n",
      "{\"data\":{\"search\":{\"hits\":[{\"id\":\"ENSG00000012048\",\"name\":\"BRCA1\",\"entity\":\"target\",\"object\":{\"associatedDiseases\":{\"rows\":[{\"score\":0.8340889978861029,\"disease\":{\"name\":\"breast-ovarian cancer, familial, susceptibility to, 1\"}},{\"score\":0.8247032876834987,\"disease\":{\"name\":\"Hereditary breast and ovarian cancer syndrome\"}}]}}}]}}}\n",
      "query generated_query {\n",
      "  search(queryString: \"Alzheimer's\", entityNames: \"disease\", page: {index: 0, size: 1}) {\n",
      "    hits {\n",
      "      id\n",
      "      name\n",
      "      object {\n",
      "        ... on Disease {\n",
      "          associatedTargets {\n",
      "            rows {\n",
      "              target {\n",
      "                id\n",
      "                approvedSymbol\n",
      "                pathways(page: {index: 0, size: 5}) {\n",
      "                  rows {\n",
      "                    pathway {\n",
      "                      id\n",
      "                      name\n",
      "                    }\n",
      "                  }\n",
      "                }\n",
      "              }\n",
      "            }\n",
      "          }\n",
      "        }\n",
      "      }\n",
      "    }\n",
      "  }\n",
      "}\n",
      "None\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "400 Client Error: Bad Request for url: https://api.platform.opentargets.org/api/v4/graphql\n",
      "{\"data\":null,\"errors\":[{\"message\":\"Unknown argument 'page' on field 'pathways' of type 'Target'. (line 13, column 26):\\n                pathways(page: {index: 0, size: 5}) {\\n                         ^\",\"locations\":[{\"line\":13,\"column\":26}]},{\"message\":\"Cannot query field 'rows' on type 'ReactomePathway'. (line 14, column 19):\\n                  rows {\\n                  ^\",\"locations\":[{\"line\":14,\"column\":19}]}]}\n"
     ]
    }
   ],
   "source": [
    "test_cases = [\n",
    "    \"What are the targets of vorinostat?\",\n",
    "    \"Find drugs that are used for treating ulcerative colitis.\",\n",
    "    \"Which diseases are associated with the genes targeted by fasudil?\",\n",
    "    \"What pathways are associated with breast cancer?\",\n",
    "    \"Find the top 2 diseases associated with BRCA1\",\n",
    "    \"Show all the diseases that have at least 5 pathways associated with Alzheimers\"\n",
    "]\n",
    "test_results = []\n",
    "test_query_results = []\n",
    "for test_case in test_cases:\n",
    "    test_result, test_query_result = test_input(test_case)\n",
    "    test_results.append(test_result)\n",
    "    test_query_results.append(test_query_result)\n",
    "    print(test_result)\n",
    "    print(test_query_result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "21deac80-2b28-42de-a1ae-08c285e729e0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1 error\n"
     ]
    }
   ],
   "source": [
    "print(sum([x is None for x in test_query_results]), \"error\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d31e766d-ef5f-4634-9dd0-4ac518c7209c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
